Literature DB >> 6327264

Protein kinase activities associated with distinct antigenic forms of polyoma virus middle T-antigen.

S M Dilworth.   

Abstract

The tyrosine-specific protein kinase activity previously described in T-antigens of polyoma virus immunoprecipitated with anti-tumour sera has been investigated using monoclonal antibodies. This activity is associated with middle T-antigen but it can be separated by selective antibody precipitation from the majority of this protein. The difference between active and inactive forms can be accounted for by an antigenic difference at the N terminus of middle T-antigen molecules. Moreover, the two different mol. wt. forms of middle T-antigen that can act as phosphoacceptors have been separated by antibody precipitation and therefore shown to be immunologically distinct. The binding position of the antibody used for immunoprecipitation has been observed to have a quantitative influence on the in vitro protein kinase reaction, in one case appearing to stimulate the activity. The detection of the in vitro protein kinase activity in immunoprecipitates obtained with several different monoclonal antibodies directed against the middle T-antigen indicates that the activity is a property tightly associated with this polyoma virus-coded protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6327264      PMCID: PMC553211          DOI: 10.1002/j.1460-2075.1982.tb01317.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

2.  Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro.

Authors:  B Schaffhausen; T L Benjamin
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

3.  Characterization of polyoma mutants with altered middle and large T-antigens.

Authors:  G Magnusson; M G Nilsson; S M Dilworth; N Smolar
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Biochemical characterization of pp60src-associated protein kinase from avian sarcoma virus Schmidt-Ruppin strain.

Authors:  P Donner; T Bunte; M K Owada; K Moelling
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

5.  DNA sequences of polyoma virus early deletion mutants.

Authors:  N Smolar; B E Griffin
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

6.  Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product?

Authors:  B E Griffin; Y Ito; U Novak; N Spurr; S Dilworth; N Smolar; R Pollack; K Smith; D B Rifkin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

Review 7.  The tumor antigens and the early functions of polyoma virus.

Authors:  H Türler
Journal:  Mol Cell Biochem       Date:  1980-09-15       Impact factor: 3.396

8.  Antibodies specific for the polyoma virus middle-size tumor antigen.

Authors:  G Walter; M A Hutchinson; T Hunter; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Polyoma virus: some considerations on its transforming genes.

Authors:  B E Griffin; S M Dilworth; Y Ito; U Novak
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-11-19

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  16 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses.

Authors:  J Forstová; N Krauzewicz; B E Griffin
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

3.  A retrovirus carrying the polyomavirus middle T gene induces acute thrombocythemic myeloproliferative disease in mice.

Authors:  A Fusco; G Portella; M Grieco; G Tajana; G Di Minno; N Polli; A Pinto
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Characterization of pp85, a target of oncogenes and growth factor receptors.

Authors:  B Cohen; Y X Liu; B Druker; T M Roberts; B S Schaffhausen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Cellular proteins that associate with the middle and small T antigens of polyomavirus.

Authors:  D C Pallas; V Cherington; W Morgan; J DeAnda; D Kaplan; B Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production.

Authors:  D C Pallas; C Schley; M Mahoney; E Harlow; B S Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression.

Authors:  M T Berlingieri; G Portella; M Grieco; M Santoro; A Fusco
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.

Authors:  S M Dilworth; V P Horner
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins.

Authors:  Z Y Zhu; G M Veldman; A Cowie; A Carr; B Schaffhausen; R Kamen
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

10.  An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites.

Authors:  R Harvey; B A Oostra; G J Belsham; P Gillett; A E Smith
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.